Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection
PHASE3CompletedINTERVENTIONAL
Enrollment
171
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
September 30, 2015
Conditions
Hepatitis C Virus
Interventions
DRUG
ABT-450/r/ABT-267
Tablet; ABT-450 coformulated with ritonavir and ABT-267